Experimental drug aims to protect unborn babies from dangerous blood condition
NCT ID NCT03842189
Summary
This study tested an experimental drug called M281 (nipocalimab) in pregnant women at high risk for a severe fetal blood disease called HDFN. The goal was to see if the drug could help babies be born alive after 32 weeks of pregnancy without needing risky blood transfusions while still in the womb. Researchers enrolled 25 women and monitored both mothers and babies for safety and effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Birmingham Children's Hospital
Birmingham, B15 2TG, United Kingdom
-
British Columbia Children's Hospital
Vancouver, British Columbia, V6H 3N1, Canada
-
CHUM - Centre hospitalier universitaire de Montreal
Montreal, Quebec, H3T 1C5, Canada
-
Columbia University Medical Center
New York, New York, 10032, United States
-
Dell Children's Medical Center of Central Texas
Austin, Texas, 78723, United States
-
Hosp. Univ. San Cecilio
Granada, 18016, Spain
-
Justus-Liebig-Universität Gießen, Kinderherzzentrum
Giessen, 35392, Germany
-
Karolinska Universitetssjukhuset Huddinge
Stockholm, SE-141 86, Sweden
-
Leiden University Medical Center
Leiden, 2333 ZA, Netherlands
-
Liverpool Hospital
Sydney, 2170, Australia
-
Mount Sinai Hospital
Toronto, Ontario, M5G 1X5, Canada
-
Oregon Health and Science University
Portland, Oregon, 97239, United States
-
Universitair Ziekenhuis Leuven
Leuven, 3000, Belgium
-
University College London Hospitals NHSFT
London, WC1E 6DB, United Kingdom
-
University of California San Francisco
San Francisco, California, 94143, United States
-
University of Cincinnati
Cincinnati, Ohio, 45267, United States
-
University of Pittsburgh
Pittsburgh, Pennsylvania, 15232, United States
-
University of Texas Health Science Center
Houston, Texas, 77030, United States
-
University of Utah
Salt Lake City, Utah, 84132, United States
Conditions
Explore the condition pages connected to this study.